Baseline imbalances in a real-world study of TKI plus radiotherapy for HCC with PVTT: Implications for interpreting survival outcomes
Biomedical Journal · 2026-12 · 49 (6) · 101022
DOI: 10.1016/j.bj.2026.101022 ↗Kurz gefasst
Leserbrief in der Zeitschrift Biomedical Journal, 2026-12. Verfasst von Siyuan Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Electronic address: 858462770@qq.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Electronic address: 858462770@qq.com.
- The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Electronic address: 19214810070@163.com.
Zitieren
APA
Zhu, S., & Zhang, P. (2026). Baseline imbalances in a real-world study of TKI plus radiotherapy for HCC with PVTT: Implications for interpreting survival outcomes. Biomedical Journal, 49(6), 101022. https://doi.org/10.1016/j.bj.2026.101022
Vancouver
Zhu S, Zhang P. Baseline imbalances in a real-world study of TKI plus radiotherapy for HCC with PVTT: Implications for interpreting survival outcomes. Biomedical Journal. 2026;49(6):101022. doi:10.1016/j.bj.2026.101022
BibTeX
@article{Zhu2026,
author = {Zhu, Siyuan and Zhang, Peiru},
title = {Baseline imbalances in a real-world study of TKI plus radiotherapy for HCC with PVTT: Implications for interpreting survival outcomes},
journal = {Biomedical Journal},
year = {2026},
volume = {49},
number = {6},
pages = {101022},
doi = {10.1016/j.bj.2026.101022}
}
EUVIMED